| The FinancialContent Network SocialPicks Community | MarketMinute Monitor | MarketMinute Market Updates | MarketMinute Stock News |
|
Analyst
|
Via StraightStocks:
Zynex Medical has been a leading provider of relief for patients with functional disability through the creation, distribution and marketing of electrotherapy products. Utilizing various methods of non-invasive muscle stimulation and state-of-the-art electromyography technology, Interferential Current (IFC) and Transcutaneous Electrical Nerve Stimulation (TENS), Zynex Medical offers patients a new lease on life by increasing mobility and providing independence. Zynex Medical also has a product for stroke victims, called NeuroMove, it is designed to increase functionality among stroke victims by teaching the healthy parts of the brain to compensate for the injured areas. NeuroMove(TM) monitors muscle activity and selects signals from the brain indicating that the patient is attempting to move a certain muscle. It then allows the particular muscle to move through electrical stimulation. Many times, the connection between the brain and muscle is restored. The techniques offered by the company are relatively new for some applications, like fibromyalgia, and can be especially helpful to those who suffer chronically from that type of condition. The fact that Zynex has had increasing orders, not just this quarter, but consistently, speaks to the quality of their product, its ease of use, and the success that existing patients are having with it. This can only bode well for them in the future, as long as Zynex can keep up with demand with the same quality and service they currently provide. Let us hear your thoughts below:
Read the rest of original post »
|
|
|
IN THE PRESS |
|
|
|
|
|
|
| About | RSS | Feedback | Contact Us | Terms of Service | Privacy |
© 2009 FinancialContent Services, Inc. |
|
Data powered by FinancialContent. All Rights Reserved. Quotes delayed at least 20 minutes unless otherwise indicated. |
|
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. |